a proof-of-concept Phase 2a clinical trial with Hbv/hdv entry inhibitor Myrcludex B : lb-20
Year: 2014
Type: article
Source: Hepatology
Authors: Pavel Bogomolov, Н. В. Воронкова, Lena Allweiss, Maura Dandri, Matthias Schwab, Florian A. Lempp, Mathias Haag, Heiner Wedemeyer, A. A. Alexandrov, Stephan Urban
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2800228895